🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

RecruitingNAAges any - 18 YearsAllUniversitas Indonesia
NCT07059689 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients under 18 years of age. * Post-cardiac surgery patients in the CICU of Cipto Mangunkusumo National General Hospital * Patients at high risk of extubation failure (e.g., young age, open sternotomy, mechanical ventilation \>48 hours). * Patients who pass the extubation readiness test and spontaneous breathing trial. Exclusion Criteria: * Diaphragmatic paralysis. * Decreased consciousness. * Neuromuscular disease. * Pneumothorax without drainage. * Airway obstruction. * Patients with a tracheostomy. * Unplanned extubation. * Patient received PEEP (Positive End-Expiratory Pressure) \>7 prior to extubation
💊

What it tests

  • High Flow Nasal Cannula (HFNC)
  • Non-Invasive Ventilation (NIV)
📍

Where

1 site
Faculty of Medicine, University of Indonesia
Jakarta, Indonesia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy